Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster

Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster

Bibliographic Details
Main Authors: Wagenhäuser, I, Reusch, J, Gabel, A, Krone, LB, Kurzai, O, Petri, N, Krone, M
Format: Journal article
Language:English
Published: Elsevier 2023

Similar Items